Markets Mackie starts CB2 Insights at speculative buy; PT $1.10 (Canadian) Mackie Research Capital initiated coverage of CB2 Insights (CSE:CBII) with a “speculative buy” rating and price target of $1.10. The stock closed at 59 cents on Oct. 23. CB2 Insights is a health care services and... October 26, 2020